Postoperative Nausea and Vomiting (PONV) Management Market

Future Market Insights

Key Insight

The postoperative nausea and vomiting (PONV) management market is projected to grow from USD 1.5 billion in 2025 to USD 5.0 billion by 2035, at a CAGR of 12.8%. Serotonin Antagonists will dominate with a 37.8% market share, while hospital pharmacies will lead the distribution channel segment with a 49.2% share.

September 10, 2025

Anurag Sharma

287 Pages

Cite this Report

Postoperative Nausea and Vomiting (PONV) Management Market

https://www.futuremarketinsights.com/reports/postoperative-nausea-vomiting-management-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Camurus AB
Eisai Co. Ltd
F. Hoffmann-La Roche Ag
GSK
Helsinn Holding S.A
Novartis
L'Oréal

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Postoperative Nausea and Vomiting (PONV) Management Market

Key Players

Similar Industry Reports